Potential Teratogenicity of Methimazole: Exposure of Zebrafish Embryos to Methimazole Causes Similar Developmental Anomalies to Human Methimazole Embryopathy
Authors:
- 29 April 2013
- journal article
- research article
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 98 (3) , 222-229
Abstract
While methimazole (MMI) is widely used in the therapy for hyperthyroidism, several groups have reported that maternal exposure to MMI results in a variety of congenital anomalies, including choanal and esophageal atresia, iridic and retinal coloboma, and delayed neurodevelopment. Thus, adverse effects of maternal exposure to MMI on fetal development have long been suggested; however, direct evidence for the teratogenicity of MMI has not been presented. Therefore, we studied the effects of MMI on early development by using zebrafish as a model organism. The fertilized eggs of zebrafish were collected immediately after spawning and grown in egg culture water containing MMI at various concentrations. External observation of the embryos revealed that exposure to high concentrations of MMI resulted in loss of pigmentation, hypoplastic hindbrain, turbid tissue in the forebrain, swelling of the notochord, and curly trunk. Furthermore, these effects occurred in a dose‐dependent manner. Precise observation of the serial cross‐sections of MMI‐exposed embryos elucidated delayed development and hypoplasia of the whole brain and spinal cord, narrowing of the pharynx and esophagus, severe disruption of the retina, and aberrant structure of the notochord. These neuronal, pharyngeal, esophageal, and retinal anomalous morphologies have a direct analogy to the congenital anomalies observed in children exposed to MMI in utero. Here, we show the teratogenic effects of MMI on the development of zebrafish and provide the first experimental evidence for the connection between exposure to MMI and human MMI embryopathy. Birth Defects Res (Part B) 98:222–229, 2013.Keywords
This publication has 37 references indexed in Scilit:
- Spectrophotometric determination of methimazole in pharmaceutical, serum and urine samples by reaction with potassium ferricyanide-Fe(III)Journal of Analytical Chemistry, 2010
- Teratogen update: antithyroid drugs—methimazole, carbimazole, and propylthiouracilTeratology, 2002
- Generating Transparent Zebrafish: A Refined Method to Improve Detection of Gene Expression During Embryonic DevelopmentMarine Biotechnology, 2001
- Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Graves' HyperthyroidismThe Journal of Clinical Endocrinology & Metabolism, 1997
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995
- Review of Antithyroid Drug Use During Pregnancy and Report of a Case of Aplasia CutisThyroid®, 1994
- Effects of thyroid antagonists on rat embryos cultured in vitroTeratology, 1990
- The behavioral effects of perinatal methimazole administration in Swiss Webster mice*1Fundamental and Applied Toxicology, 1987
- Pharmacokinetic Properties and Bioavailability of MethimazoleClinical Pharmacokinetics, 1985
- Ubiquity of Melanin and the Effect of PhenylthioureaNature, 1966